Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, Kuttke M, Liutkevičiūtė Z, Göransson U, Gründemann C, et al. Proc Natl Acad Sci U S A. 2016 Mar 28. PMID: 27035952. Abstract CommentRecommendBookmarkWatch